Skip to main content

Table 1 Baseline characteristics, cardiac parameters derived from magnetic resonance imaging, and serum troponin levels.

From: Prognostic implications of myocardial fibrosis and troponin levels measured by a highly sensitive assay in non-ischemic cardiomyopathy

Variable*

 

Fibrosis Absent (n = 39)

Fibrosis Present (n = 35)

Age (years)

 

58 (44, 68)

58 (45, 70)

Male (%)

 

61.5

60.0

Race (%)

White

56.4

60.0

 

Black

25.6

22.9

 

Hispanic

5.1

8.6

 

Asian

0

5.7

 

Other

12.8

2.9

Hypertension (%)

 

56.8

50.0

Dyslipidemia (%)

 

38.9

50.0

Diabetes (%)

 

11.1

16.1

Smoking History (%)

Former (>1 year)

22.9

20.0

 

Current

5.7

16.7

Height (ins.)

 

69 (66, 73)

68.5 (65.5, 70)

Weight (lbs.)

 

200 (162, 230)

195 (146.5, 233)

Body surface area (m^2)

 

2.09 (1.85, 2.30)

2.05 (1.79, 2.28)

Systolic blood pressure (mm Hg)

 

117 (111,141)

117 (108, 133)

Diastolic blood pressure (mm Hg)

 

76 (65, 81)

71 (64, 82)

Heart rate (bpm)

 

80 (70, 86)

74 (64, 86)

Left atrial volume (mL)

 

109 (87, 165)

122 (87, 179)

Left ventricular ejection fraction (%)

 

37 (27, 45)

35 (27, 46)

Left ventricular end-diastolic volume (mL)

 

200 (156, 238)

214 (170, 264)

Left ventricular end-systolic volume (mL)

 

127 (80, 155)

133 (88, 185)

Left ventricular stroke volume (mL)

 

68 (53, 79)

74 (63, 91)

Left ventricular muscle mass (gm)

 

127.95 (128.00, 201.40)

177.00 (132.70, 223.00)

Left ventricular fibrosis percentage (%)†

 

0.00 (0.00, 0.00)

3.00 (2.00, 7.00)

Troponin T (ng/L)

 

8.0 (4.0, 21.0)

14.0 (7.0, 21.0)

  1. *All values are proportions or median (interquartile range).
  2. †p <0.05 (by Chi-squared or Fisher exact for categorical variables as appropriate; Wilcoxon rank sum test for continuous variables).